Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six analysts that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock …
Disparate projects have resulted in several systemic challenges, says the Department of Home Affairs. Read Full Article →
DALLAS , May 11, 2026 /PRNewswire/ -- The Spirits League, an alliance of owner-operated, multi-generational beer and spirits distributors, has launched a custom-built digital portal in partnership with Tegan Digital, establishing a platform to improve collaboration and performance across its supplier and distributor network. The portal was developed to support the
Why does a product that retails in only dozens of batches in Türkiye sell hundreds of units a day in Russia? Turkish pharmacist Cihat Aygün found the answer to this question: after... Read Full Article →
Here are Monday's biggest calls on Wall Street. Read Full Article →